Evidence map›Paper›PMID 32181490›Full record

ReviewFEBS letters2020

Complement in malaria: immune evasion strategies and role in protective immunity.

Patience Kerubo Kiyuka, Seppo Meri, Ayman Khattab

Open access · hybridAbstract readReview
In one paragraph

Review in FEBS letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Immunity beyond borders: non-lethalFrontiers in immunology · 2026
    Article
  3. Article
  4. Review
  5. Host complement C3 promotes malaria transmission by killing symbiotic bacteria in the mosquito midgut.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Host-parasite interactions duringFrontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 5 countries.

Patience Kerubo KiyukaDepartment of Bacteriology and Immunology, Translational Immunology Research Program, Haartman Institute, University of Helsinki, Finland.ORCID 0000-0002-3257-5920
Seppo MeriDepartment of Bacteriology and Immunology, Translational Immunology Research Program, Haartman Institute, University of Helsinki, Finland.ORCID 0000-0001-9142-501X
Ayman KhattabDepartment of Bacteriology and Immunology, Translational Immunology Research Program, Haartman Institute, University of Helsinki, Finland.ORCID 0000-0002-3980-8379
University of Helsinki · FI

Funding

Wellcome TrustWellcome Trust 107769/Z/10/Z
6 · The paper itself

Abstract

The malaria parasite has for long been thought to escape host complement attack as a survival strategy. However, it was only recently that complement evasion mechanisms of the parasite were described. Simultaneously, the role of complement in antibody-mediated naturally acquired and vaccine-induced protection against malaria has also been reported. Such findings should be considered in future vaccine design, given the current need to develop more efficacious vaccines against malaria. Parasite antigens derived from molecules mediating functions crucial for parasite survival, such as complement evasion, or parasite antigens against which antibody responses lead to an efficient complement attack could present new candidates for vaccines. In this review, we discuss recent findings on complement evasion by the malaria parasites and the emerging role of complement in antibody-mediated protection against malaria. We emphasize that immune responses to vaccines based on complement inhibitors should not only induce complement-activating antibodies but also neutralize the escape mechanisms of the parasite.

Indexed as

Complement ActivationImmune EvasionAnimalsAntibodies, ProtozoanComplement System ProteinsHumansMalariaPlasmodiumAntibodies, ProtozoanComplement System ProteinscomplementimmunitymalariaPlasmodium

Identifiers

PMID32181490
PMCPMC8653895
OpenAlexW3011810788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.